These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 9613981

  • 21. Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome.
    Dummer R, Nestle FO, Niederer E, Ludwig E, Laine E, Grundmann H, Grob P, Burg G.
    Arch Dermatol Res; 1999 Jun; 291(6):307-11. PubMed ID: 10421055
    [Abstract] [Full Text] [Related]

  • 22. IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.
    Yoon JS, Newton SM, Wysocka M, Troxel AB, Hess SD, Richardson SK, Lin JH, Benoit BM, Kasprzycka M, Wasik MA, Rook AH.
    J Invest Dermatol; 2008 Feb; 128(2):473-80. PubMed ID: 17713571
    [Abstract] [Full Text] [Related]

  • 23. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
    Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Lenz J, Speuser P, Erdmann S, Abuzahra F, Bowman E, Roszkiewicz J, Bieber T, Tüting T.
    Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
    [Abstract] [Full Text] [Related]

  • 24. Immunological milieu in mycosis fungoides and Sézary syndrome.
    Miyagaki T, Sugaya M.
    J Dermatol; 2014 Jan; 41(1):11-8. PubMed ID: 24438139
    [Abstract] [Full Text] [Related]

  • 25. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R, Quaglino P, Novelli M, Fierro MT, Comessatti A, Peroni A, Bonello L, Bernengo MG.
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [Abstract] [Full Text] [Related]

  • 26. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
    Otobe S, Sugaya M, Nakajima R, Oka T, Takahashi N, Kabasawa M, Miyagaki T, Asano Y, Sato S.
    J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
    [Abstract] [Full Text] [Related]

  • 27. Chromosomally clonal T cells in the skin, blood, or lymph nodes of two Sezary syndrome patients express CD45RA, CD45RO, CDw150, and interleukin-4, but no interleukin-2 or interferon-gamma.
    Karenko L, Nevala H, Raatikainen M, Franssila K, Ranki A.
    J Invest Dermatol; 2001 Jan; 116(1):188-93. PubMed ID: 11168816
    [Abstract] [Full Text] [Related]

  • 28. Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sézary syndrome.
    van der Fits L, Out-Luiting JJ, van Leeuwen MA, Samsom JN, Willemze R, Tensen CP, Vermeer MH.
    J Invest Dermatol; 2012 Feb; 132(2):440-7. PubMed ID: 21938013
    [Abstract] [Full Text] [Related]

  • 29. Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients.
    Bensussan A, Remtoula N, Sivori S, Bagot M, Moretta A, Marie-Cardine A.
    J Invest Dermatol; 2011 Apr; 131(4):969-76. PubMed ID: 21191411
    [Abstract] [Full Text] [Related]

  • 30. FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.
    Heid JB, Schmidt A, Oberle N, Goerdt S, Krammer PH, Suri-Payer E, Klemke CD.
    J Invest Dermatol; 2009 Dec; 129(12):2875-85. PubMed ID: 19626037
    [Abstract] [Full Text] [Related]

  • 31. Interleukin-7 is a growth factor for Sézary lymphoma cells.
    Dalloul A, Laroche L, Bagot M, Mossalayi MD, Fourcade C, Thacker DJ, Hogge DE, Merle-Béral H, Debré P, Schmitt C.
    J Clin Invest; 1992 Sep; 90(3):1054-60. PubMed ID: 1381718
    [Abstract] [Full Text] [Related]

  • 32. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).
    Cirée A, Michel L, Camilleri-Bröet S, Jean Louis F, Oster M, Flageul B, Senet P, Fossiez F, Fridman WH, Bachelez H, Tartour E.
    Int J Cancer; 2004 Oct 20; 112(1):113-20. PubMed ID: 15305382
    [Abstract] [Full Text] [Related]

  • 33. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.
    Br J Dermatol; 2006 Oct 20; 155(4):756-62. PubMed ID: 16965425
    [Abstract] [Full Text] [Related]

  • 34. Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.
    Tendler CL, Burton JD, Jaffe J, Danielpour D, Charley M, McCoy JP, Pittelkow MR, Waldmann TA.
    Cancer Res; 1994 Aug 15; 54(16):4430-5. PubMed ID: 7913876
    [Abstract] [Full Text] [Related]

  • 35. Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma.
    Weng WK, Armstrong R, Arai S, Desmarais C, Hoppe R, Kim YH.
    Sci Transl Med; 2013 Dec 04; 5(214):214ra171. PubMed ID: 24307695
    [Abstract] [Full Text] [Related]

  • 36. [Sézary syndrome. Clinical, immunological and proliferative kinetics].
    Marosi L, Hofer F, Schwarzmeier J, Konrad K, Knapp W, Radaskiewicz T.
    Acta Med Austriaca; 1979 Dec 04; 6(5):237-40. PubMed ID: 318012
    [Abstract] [Full Text] [Related]

  • 37. New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome.
    Furue M, Kadono T.
    J Dermatol; 2015 Oct 04; 42(10):941-4. PubMed ID: 26432429
    [Abstract] [Full Text] [Related]

  • 38. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells.
    Döbbeling U, Dummer R, Laine E, Potoczna N, Qin JZ, Burg G.
    Blood; 1998 Jul 01; 92(1):252-8. PubMed ID: 9639524
    [Abstract] [Full Text] [Related]

  • 39. A restricted clonal T-cell receptor αβ repertoire in Sézary syndrome is indicative of superantigenic stimulation.
    van der Fits L, Sandberg Y, Darzentas N, Zoutman WH, Tielemans D, Wolvers-Tettero IL, Vermeer MH, Langerak AW.
    Br J Dermatol; 2011 Jul 01; 165(1):78-84. PubMed ID: 21410672
    [Abstract] [Full Text] [Related]

  • 40. Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome.
    Möbs M, Gryzik S, Haidar A, Humme D, Beyer M, Vandersee S.
    Arch Dermatol Res; 2015 Aug 01; 307(6):479-85. PubMed ID: 25488078
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.